Electroporation -mediated gene transfer relies upon direct delivery of plasmids into cells permeabilized by electric fields, a method more efficient than transfer using nonviral vectors, although neither approaches the transfer efficiency of viral vectors. Here we studied electrotransfer of a gene encoding an angiogenesis inhibitor ( endostatin ) into primary tumors and muscle tissues, which would serve as a site of synthesis and secretion into the bloodstream of a therapeutic antimetastatic protein with systemic effects. Optimum electroporation conditions ( voltage, number and duration of impulses, separation of caliper electrodes ) were first established to maximize expression of a reporter gene transferred into murine Renca kidney carcinoma, B16( F10 ) melanoma, or skeletal muscle tissues. In neoplastic tissues, electrotransfer of plasmid DNA was far more efficient than electroporation with lipoplexes, but no differences between naked DNA and lipoplexes were found in case of electroporated muscles. We then studied the electrotransfer of plasmid DNA carrying the endostatin gene into pre -established experimental Renca tumors. A significant inhibition of tumor growth was observed in animals electroporated with this construct. Electrotransfer of the endostatin gene into muscle tissues resulted in reduced numbers of experimental B16( F10 ) metastases in the lungs. This study clearly shows that electroporation may be used to efficiently transfer antiangiogenic genes into both normal and neoplastic tissues.
T he basic concept underlying gene therapy, at least for genetic diseases, is quite simple: to provide cells with an abnormal phenotype with DNA carrying the gene that compensates for the defect (see, for reviews, Somia and Verma 1 and Mountain 2 ), thus addressing the cause rather than the symptoms of the disease. (As a rule, in case of genetic diseases, a nonmutated form of the gene in question is to be delivered. ) As carriers of such extraneous DNA, both viral 3 and nonviral 4 vectors are used, and generally speaking, viral carriers are highly efficient albeit immunogenic, whereas nonviral carriers are not immunogenic but their efficiency of gene transfer is much lower. Further progress in clinical applications of gene therapy appears to depend, to a greater extent, on the availability of new DNA carriers and methods of transfer than on availability of new genetic constructs. 1 Similar difficulties are encountered in gene therapy of cancer (see, for review, Gómez -Navarro et al 5 and Vile et al 6 ) where problems concern not only transfer methods and carriers of therapeutic genes but also new constructs for direct or indirect destruction of cancer cells. A promising, far -reaching approach to gene therapy of cancer is offered by the concept of antiangiogenic strategy, 7 -10 which relies upon transfecting genes encoding inhibitors of neoplastic angiogenesis. 11, 12 These prevent formation of new vessels within the growing tumor, leading to its growth arrest and, in some cases, to its regression. Several studies have shown that endostatin or angiostatin effectively blocks growth of primary tumors ( see, for a recent review, Feldman and Libutti 10 ). A particularly suitable application of gene therapy to cancer is an antimetastatic strategy because there are currently no efficient methods of preventing or destroying metastases, and therapy based on the use of genes inhibiting neovascularization of tumors offers a great deal of hope. 7 Here we have studied the ability of an antiangiogenic approach to prevent metastases to the lung of experimentally induced murine B16( F10 ) melanoma. The hypothesis that this strategy can indeed affect metastasis formation has been supported by a number of studies (see, for review, Feldman and Libutti 10 ). The novelty of our approach consists of applying the electroporation method to carry the angiostatic endostatin gene 13, 14 into both neoplastic and normal tissues (muscles ). So far, the endostatin gene has been transferred in vivo using a variety of carriers, among them adeno -associated viruses, 15 adenoviruses, 16 polymerized plasmids, 17 cationic liposome -DNA complexes, 18 naked DNA, 19 and so forth. Several reports have established that electroporation in vivo may be used to transfer therapeutic genes (see, for review, Mir 20 ). We examined factors that influence results obtained with electroporation method such as the targeted tissue, the impulse -generating equipment, the characteristics of the electrodes, and the voltage and duration of impulses 21, 22 in order to maximize gene transfer into muscles and tumors.
Materials and methods

Plasmids
The plasmid constructs used were: pVR1255 encoding the luciferase gene under the control of the CMV promoter, and pVR1012 ( suitable for cloning and gene expression 23 ), both from Dr RH Zaugg (Vical, San Diego, CA ); pEGFP-GL3 encoding the green fluorescent protein (GFP ) gene under the control of the SV40 T -antigen promoter (from Drs A Wysocka and Z Krawczyk, Tumor Biology Department, Maria SkJodowska -Curie Memorial Institute ); pCMVnlacZ showing nuclear localization (obtained from Dr L Sadzinska, Université de Génève, Faculté de Biologie Moléculaire, Génève, Switzerland ); and pVR1012/ endostatin encoding the murine endostatin gene under the control of the CMV promoter. 19 Plasmid DNA was isolated and purified from contaminating endotoxin using Sephacryl columns 24 ( Sephacryl S-1000 Superfine, 1.6Â100 cm; Pharmacia Biotech, Freiburg, Germany ). Endotoxin levels in purified DNA (0.03 EU / g of DNA ) were determined using a kit containing Limulus Amebocyte Lysate ( Biowhittaker, Rockland, ME ) as specified.
Cationic DC -Chol / DOPE liposomes DC -Chol/DOPE liposomes were synthesized according to Gao Electrotransfer of plasmid encoding endostatin into Renca and B16( F10 ) tumors. Five mice were used in each control or experimental group. When tumors reached 5-6 mm in diameter, mice were anesthesized with Avertin ( 0.015 -0.017 mL /g body weight ) using a 2.5% dilution of a 100% stock (10 g of tribromoethyl alcohol in 10 mL of tertamyl alcohol). 27 Mice from a first control group received 100 L of PBS À injected directly into the tumor, whereas the second group received 10 g of pVR1012 plasmid DNA ( empty vector )/100 L of PBS À . The experimental group received 10 g of plasmid pVR1012 DNA containing the endostatin gene per 100 L of PBS À . Following injection, the tumors were entirely covered with ultrasound gel and placed between 10-mm -diameter caliper -type electrodes ( Treezetrode, MDL542; BTX, a division of Genetronics, San Diego, CA ) set 3 mm apart, and electroporated with square wave pulses ( 200 V, 100 milliseconds ) from an ElectroSquare Porator ECM830 ( BTX ). Electroporation was repeated every second day. Tumor volume was calculated using the formula:
13 width 2 ÂlengthÂ0.52.
Electroporation of tibial muscle cells
Mice were anesthesized using Avertin and their legs were carefully shaved. Ten micrograms of plasmid DNA /100 L of PBS À was injected into the hind limb tibial muscles, the legs were entirely covered with ultrasound gel, and placed between caliper -type electrodes 5 mm apart and electroporated (900 V, 100 microseconds ).
B16( F10 ) lung metastases
C57BL / 6 mice were anesthesized with Avertin and inoculated with a single cell suspension of B16( F10) cells (1Â10 6 / 100 L of PBS À ) through the tail vein. On the fourth day following inoculation, 10 g of plasmid pVR1012 DNA containing the endostatin gene per 100 L of PBS À was injected into both hind leg tibial muscles. Mice from the control group received 10 g of plasmid DNA pVR1012 ( empty vector ) per 100 L of PBS À . The electroporation conditions were 5 mm spacing, 5 impulses of 900 V, 100 microseconds, repeated after 7 days. After 3 weeks, the mice were sacrificed, the lungs fixed in standard Bouin's solution, 28 and metastases counted using a magnifying lens.
Detection of b -galactosidase activity
The activity of -galactosidase in cells transfected with pCMVnlacZ was detected by staining with X -gal as described by Budryk et al. 29 Cancer Gene Therapy
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Statistical analyses
The difference in the number of lung metastatic nodules between two groups of animals was analyzed by the MannWhitney U nonparametric test.
Results
Optimization of reporter gene electroporation into muscle cells
A series of experiments was carried out to optimize the amount of DNA and solvent injected, as well as the impulse voltage, duration, and number. Two distinct maxima of luciferase gene expression levels were seen in electroporated muscle cells depending on the voltage -that at 100 V was termed ''low'' and the second at 900 V ''high'' ( Fig 1A ) . The optimum impulse duration at these voltages was 50 and 100 microseconds, respectively; longer impulses caused muscle damage ( data not shown). The optimum separation of the caliper electrodes was 5 mm and of the amount of DNA was 10 g ( see Table 1 ). The optimum voltage for luciferase expression was first determined as described in Figure 1 . Then, using this voltage, the other parameters also affecting reporter gene expression were optimized. In all cases, DNA was dissolved in PBS À . From among several solvents for DNA (PBS À , 0.9% NaCl, Ringer's solution ), PBS À was the most suitable (data not shown ). It was noteworthy that electroporation could be accomplished through the skin without exposing the naked muscles. The efficiency of electroporation was markedly increased if the skin in contact with the electrodes was covered with ultrasonography gel ( data not shown ). When endotoxin was present in the DNA preparation (ca. 20 EU of endotoxin /g of DNA ), reporter gene expression was markedly ( 10-fold ) decreased compared to DNA containing 0.03 EU of endotoxin /g of DNA. Table 1 summarizes the optimum conditions for electroporation of murine muscle.
Optimization of reporter gene electroporation into Renca and B16( F10 ) tumors
The best expression of the luciferase reporter gene after electroporating Renca and B16( F10 ) tumors was achieved at 200 V (Fig 1B ) , and at higher voltages, no expression maximum was seen, whereas marked tissue damage occurred. An electrode spacing of 3 mm and a single impulse of 100 milliseconds were the most effective. As in the case of muscle, the optimum amount of injected plasmid DNA was 10 g, the best solvent PBS À , and efficiency was higher when tumors were covered with ultrasonography gel. The optimization procedure was ( Fig 3A ) or Renca tumor tissue ( B ) were injected with either 10 g of plasmid DNA alone or plasmid DNA complexed to cationic liposomes DCChol / DOPE, in both cases using 200 L of PBS À . Plasmid DNA and DC -Chol / DOPE liposomes were complexed at 1:1 ( wt / wt ) ratio. The following optimized conditions were used to electroporate muscles: 5 impulses, 100 V, 50 milliseconds, distance between caliper electrodes 5 mm; or 5 impulses, 900 V, 100 microseconds, distance between caliper electrodes 5 mm. The following optimized conditions were used to electroporate tumors: 1 impulse, 200 V, 100 milliseconds, distance between caliper electrodes 3 mm; or 3 impulses, 1100 V, 150 microseconds, distance between caliper electrodes 3 mm. Twenty -four hours after electroporation, muscles or tumor tissues were excised and homogenized. Luciferase activity in tissue lysates was measured as described in Materials and methods. Zero V -no electroporation. 
The optimum voltage for luciferase expression was first determined as described in Figure 1 . Then, using this voltage, the other parameters also affecting reporter gene expression were optimized. In all cases, DNA was dissolved in PBS À . Ten micrograms of pVR1255 plasmid DNA in 100 L of PBS À was injected into muscle or tumor. Mouse skin, covered with ultrasonography gel, was placed between 10 -mm -diameter caliper electrodes ( Treezertrode, MDL452 ). The distance between electrodes was 5 mm in case of muscle electroporation, and 3 mm for tumors ( tumor diameter was 5 -6 mm ). Muscle electroporation was achieved with five impulses of either ''low'' voltage ( 50, 100, or 200 V ) and 50 milliseconds duration, or ''high'' voltage ( 600, 900, or 1200 V ) and 100 microseconds duration. Tumor electroporation parameters were as follows: ''low'' voltage ( 100, 200, or 500 V ), impulse duration 100 milliseconds; ''high'' voltage ( 600 -1200 V ), impulse duration 150 microseconds. Twenty -four hours following electroporation, muscles and tumors were excised and luciferase activity was determined in tissue homogenates using suitable commercial kit ( Promega ). Bars show average RLU ± SD per 1 mg of protein in lysate from 10 muscles ( A ), and average RLU ± SD per 1 mg of protein in lysate from five tumors ( B ). Zero V -no electroporation.
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Transgene localization
Having established the optimum electroporation conditions for muscles and tumors (Renca), the localization of the transgene product was examined by electrotransfer of plasmid pEGFP-GL3 containing the GFP gene. In both muscle and tumors, GFP fluorescence was localized within cells in the area of contact with the electrodes and no fluorescent cells were found in control tumors or muscle tissue injected with PBS À ( data not shown ). Using optimized electroporation conditions ( 900 V, 100 microseconds, 5 impulses, electrode distance 5 mm, 10 g of DNA in 100 L of PBS À , muscle tissue collected after 48 hours ), the percentage of X -gal -stained (transfected ) cells was found to be approximately 3%.
Electroporation of plasmid DNA complexed to DC -Chol / DOPE cationic liposomes
Based on the optimized conditions above, experiments was carried out to assess the applicability of DNA cationic liposome complexes for electrotransfer. Plasmid DNA alone electroporated into tumors yielded an expression of the reporter gene one order of magnitude greater than the same DNA complexed to DC -Chol/DOPE cationic liposomes (Fig 2B ) . On the other hand, in muscle tissues, there was no significant difference in transfection efficiency ( Fig 2A ) .
Electroporation of the endostatin gene into Renca tumors
Endostatin -coding plasmid DNA (10 g ) was injected into tumors with 5 -6 mm diameter, which developed 10 days after inoculation with 1Â10 6 Renca cells, followed by electroporation repeated every second day until day 30. In the group of mice treated by electroporation of the endostatin-coding gene, there was a distinct inhibition of tumor growth compared to control mice injected with PBS À or empty vector (Fig 3) .
Electroporation of the endostatin gene into muscles and inhibition of metastasis
To examine if endostatin -coding plasmid DNA transferred into muscles was expressed to give a high level of circulating endostatin, 10 g of plasmid DNA encoding the endostatin gene or of empty vector DNA was electroporated into the tibial muscles of four BALB / c mice. After 7 days, peripheral blood was collected and endostatin was assayed in plasma by ELISA. The endostatin level in the blood of mice treated with the endostatin construct was markedly higher ( Fig 4 ) .
These data allowed the formulating of a preliminary antimetastatic therapy protocol. On the fourth and seventh days following intravenous injection of 1Â10 6 B16(F10) melanoma cells into the tail vein of C57BL /6 mice, the animals underwent muscle electroporation of 10 g of plasmid DNA containing the endostatin gene. Three weeks after inoculation with the neoplastic cells, the mice were sacrificed, the lungs excised and fixed, and metastatic foci counted. A clear difference was seen between the number Figure 4 Endostatin concentrations in plasma following electroporation of plasmid DNA into muscles. BALB / c female mice were electroporated into both hind limb tibial muscles with 10 g of plasmid DNA ( either containing endostatin gene or empty plasmid ) in 100 L of PBS À . Electroporation conditions: 5 impulses, 900 V, 100 microseconds, distance between caliper electrodes 5 mm. Seven days after transfer of plasmid DNA, peripheral blood was collected using EDTA. Plasma concentration of endostatin was measured using a commercial kit ( Accucyte Murine Endostatin Immunoassay Kit ) from Cytimmune Science. Each group numbered four animals. On the 10th day after inoculation, therapy was initiated. First, plasmid DNA containing endostatin gene or ''empty'' plasmid DNA ( pVR1012 ) at 10 g / 100 L of PBS À was injected into tumors and such administrations were repeated every second day until the 30th day of the experiment. Following each injection, tumors were electroporated. Electroporation conditions: 1 impulse, 200 V, 100 milliseconds, distance between caliper electrodes 3 mm. Experimental groups numbered five animals. Each data point represents average tumor volume ( ± SD ) on the given day of the experiment. Differences between study and control ( ''empty'' plasmid ) group were statistically significant ( P < .02, Mann -Whitney U -test ).
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Discussion
The present study is, to the best of our knowledge, the first attempt to adapt the techniques of electroporation to transfer endostatin, 13, 14 one of the most promising angiostatic genes, into normal or neoplastic cells. This method of transfer of a foreign gene is simple and the plasmid DNA may be transferred repeatedly into any type of tissue. The efficiency of transfer, although lower than that with viral vectors, is nonetheless higher than that offered by nonviral lipoplexes whose efficiency of transfer into tumors does not exceed 1.7%, 30 whereas electroporation can yield 3 -8% of transfected tumor cells 31 and up to 10% of muscle cells 32 ( in our hands, however, transfection efficiency of muscle cells was 3% ). In order to successfully adapt electroporation to gene transfer into tissues and to exclude large interexperimental variability, several parameters must be optimized for a given organ or tissue including voltage, number and duration of impulses, distance between electrodes, and so forth ( Table 1) . 20 -22 In our experience, direct contact of muscles with the electrodes during electroporation is not necessary, although muscle exposure has been advocated by some investigators ( e.g., Vicat et al 32 ) . Firm contact of the electrodes with the skin and the use of ultrasonography gel enable gene transfer to the underlying tissues. In muscles, we observed two maxima of optimum voltage, which yielded the best transfection efficiency (Fig 1A ) , as observed by Vicat et al. 32 On the other hand, in tumors, a single voltage optimum for maximum gene expression was found (Fig 1B ) . There was no improvement of gene transfer efficiency beyond a threshold voltage and distinct tissue damage could be seen at higher voltages and especially at combinations of higher voltage and longer impulse times. In our opinion, the best combination is a low voltage for a short time, when tissue damage is minimized. Contrary to the findings of Wells et al, 33 in our hands, electroporation of neoplastic tissues was much more efficient ( by one order of magnitude ) when naked plasmid DNA was used without recourse to cationic lipids compared to lipoplexes (Fig 2B ) . However, in muscle tissues, no differences were seen in gene expression levels when plasmid DNA was compared with complexes with cationic liposomes (Fig 2A ) . These observations suggest that there exist differences, so far unexplained, between muscle tissue and tumors in the electrotransfer of naked DNA or of DNA complexed with lipoplexes.
We used electroporation to transfer the gene encoding endostatin, 13, 14 inserted this into an expression vector, and confirmed the expression of this protein. 19 Our data (Fig 3) demonstrate that electrotransfer of a therapeutic gene may be successfully carried out on much larger tumors than transfer involving only injection of DNA; electrotransfer was carried out on tumors reaching 5 -6 mm in diameter, whereas passive transfer of DNA is most efficient on tumors not exceeding 1-2 mm. 19 The efficiency of gene transfer by electroporation is greater by several orders of magnitude than that of passive DNA transfer (see Fig 1) . Electrotransfer of the endostatin gene into normal tissues ( muscle ) could also be achieved (Fig 4) and several previous studies have indicated that electrotransfer into muscle of other therapeutic genes such as those encoding interleukin -12 (e.g., Hanna et al 34 ) and erythropoietin ( e.g., Rizzuto et al 35 ) or FGF 1 ( e.g., Mir et al 36 ) is very effective. Transfer of the endostatin gene into muscles resulted in augmented levels of circulating endostatin ( Fig 4) and diminished the number of metastatic foci in mouse lungs ( Fig 5) ( see also Blezinger et al 17 ) . The level of endostatin transfection obtained in our study is different from that obtained by others (e.g., Refs. [16] [17] [18] . So far, we cannot provide adequate explanation for this observation ( for more detailed discussion, see Feldmann and Libutti 37 and Mixson 38 ). Thus, our data suggest that one of the basic objectives of antiangiogenic gene therapy strategy -the production and secretion by normal tissues of antiangiogenic proteins exerting systemic effects 7,17,39 -43 -may be achievable. Ultimately, the success of gene therapy depends foremost on the availability of effective gene transfer methods. Antiangiogenic constructs coupled with electroporation appear to be a potentially interesting strategy for gene transfer into normal tissues. Although the efficiency of DNA electrotransfer does not match that of virally mediated transfer, it offers the important possibility of repetitive use and here has yielded promising therapeutic results. 
Note added in proof
A recently described electrotransfer method including pretreatment of skeletal muscle with hyaluronidase increases transgene expression. 44 
